nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR1B—GPCR downstream signaling—AKT1—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CDKN1B—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CCND1—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CCND1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CCND1—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—AKT1—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MDM2—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MDM2—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—HRAS—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CCND1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CDKN1A—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CDKN1A—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—TP53—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CDKN1A—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CCND1—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—AKT1—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—AKT1—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CDKN1A—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—AKT1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CDKN1A—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—HRAS—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EP300—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EP300—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—HRAS—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—AKT1—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EP300—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CCND1—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—HRAS—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—AKT1—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EP300—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CDKN1B—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MDM2—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—AKT1—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EP300—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MDM2—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CCND1—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—AKT1—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—TP53—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CCND1—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EP300—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CDKN1A—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—HRAS—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GNA11—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—AKT1—ocular cancer	0.0002	0.0002	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—MYC—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—MYC—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TGFB1—ocular cancer	0.000197	0.000197	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—AKT1—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TGFB1—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MYC—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TGFB1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EP300—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—EP300—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EP300—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MYC—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MYC—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCND1—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MDM2—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EP300—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000173	0.000173	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EP300—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000159	0.000159	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—EP300—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCND1—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—HRAS—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—HRAS—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—HRAS—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—HRAS—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EP300—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—ocular cancer	0.000146	0.000146	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EP300—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EP300—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—HRAS—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—ocular cancer	0.000139	0.000139	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—HRAS—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—HRAS—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000124	0.000124	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—ocular cancer	0.000122	0.000122	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—HRAS—ocular cancer	0.00012	0.00012	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—HRAS—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—HRAS—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—ocular cancer	0.000105	0.000105	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000105	0.000105	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—EP300—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—HRAS—ocular cancer	9.89e-05	9.89e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—HRAS—ocular cancer	9.87e-05	9.87e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	9.79e-05	9.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	9.69e-05	9.69e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—ocular cancer	9.51e-05	9.51e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—ocular cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	9e-05	9e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—ocular cancer	8.88e-05	8.88e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—ocular cancer	8.74e-05	8.74e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—ocular cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—EP300—ocular cancer	8.68e-05	8.68e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	8.55e-05	8.55e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—EP300—ocular cancer	6.7e-05	6.7e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—ocular cancer	6.19e-05	6.19e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—ocular cancer	5.25e-05	5.25e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—ocular cancer	4.05e-05	4.05e-05	CbGpPWpGaD
